Clinical Trials
Source: CCM
- Score: 3Children's Health, Headaches
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)
- Ages6 years - 17 years
- GenderBoth
- Score: 2Headaches
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)
- Ages6 years - 17 years
- GenderBoth
- Score: 1Children's Health, Endocrine System, Genetics, Mental Health & Behavioral Research
Yale Center for Clinical Investigation (YCCI) Specimen and Data Repository
- Ages7 years - 70 years
- GenderBoth